| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73327378bc59f3b1425e610b29f34079
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21050ef701ca2e084ebee7551a42d945 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- |
| filingDate |
2007-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_055057113090a430f94803cb0c0792e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b6e718fda383cea3066e536cf891cb4 |
| publicationDate |
2007-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007213403-A1 |
| titleOfInvention |
Tamoxifen response in pre-and postmenopausal breast cancer patients |
| abstract |
The present invention relates to the use of an inhibitor of the VEGFR2 receptor in the preparation of a pharmaceutical preparation for improving tamoxifen treatment response in pre- and postmenopausal breast cancer patients being estrogen receptor positive. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014018253-A1 |
| priorityDate |
2004-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |